Upon adjusting for BMI, the association between the variant at the FTO locus was no longer significantly associated with NAFLD, confirming that the effect of this variant on NAFLD is dependent on its effect on body weight. The gene discussed is FTO; the disease is metabolic dysfunction-associated steatotic liver disease.